VeriSeq™ NIPT Solution v2: Expect the extraordinary in prenatal screening

April 18, 2023

VeriSeq NIPT Solution v2. A workflow that works with you. Ease: A simple, easy-to-use, automated system that seamlessly integrates into your lab’s current workflow and flexes with your lab’s growing needs. Accuracy: An in-lab IVD NIPT screening assay solution that delivers high accuracy with greater than or equal to 99.9% sensitivity and specificity. Results you and your clinicians can trust. Speed: Results in approximately 26 hours with only 2 hours of hands-on time means clinicians and their expecting families get answers faster. For In Vitro Diagnostics Use. Not available in all regions and countries. Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos Facebook: LinkedIn: Instagram: Twitter:

Share this article on